alpha-aminopyridine has been researched along with Hypertension, Pulmonary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catherinot, E; Chabrol, A; Chaumais, MC; Couderc, LJ; Doubre, H; Fraboulet, S; Friard, S; Hamid, AM; Mayenga, M; Metivier, AC; Montani, D; Rivaud, E; Salvator, H; Tcherakian, C | 1 |
| Brennan, S; Ghaly, Y; Gurney, AM; Herget, J; Joshi, S; Mizera, R; Novotna, J; Sedivy, V; Zaloudikova, M | 1 |
| Adnot, S; Eddahibi, S; Hatzelmann, A; Izikki, M; Klar, J; Marx, D; Raffestin, B; Tenor, H; Zadigue, P | 1 |
| Gurney, AM; MacLean, MR; Morecroft, I; Murray, A; Nilsen, M | 1 |
| Gillissen, A; Häussermann, A | 1 |
| Cortijo Gimeno, J; Morcillo Sánchez, E | 1 |
| Ganz, R; Levy, PS; Rich, S | 1 |
| Packer, M | 1 |
3 review(s) available for alpha-aminopyridine and Hypertension, Pulmonary
| Article | Year |
|---|---|
[Diseases of the lung and air passages 2010].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones | 2010 |
[Pharmacological profile of roflumilast].
Topics: Airway Remodeling; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Division; Cilia; Cyclopropanes; Drug Evaluation, Preclinical; Fibroblasts; Humans; Hypertension, Pulmonary; Macrophages; Mice; Molecular Structure; Mucus; Myocytes, Smooth Muscle; Neutrophils; Nicotiana; Oxidants; Oxidative Stress; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Smoke | 2010 |
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Blood Pressure; Calcium Channel Blockers; Captopril; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Hypotension; Lung; Oxygen; Oxygen Inhalation Therapy; Parasympathomimetics; Prostaglandins; Pulmonary Artery; Vascular Resistance; Vasodilator Agents | 1985 |
5 other study(ies) available for alpha-aminopyridine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Lorlatinib - Induced pulmonary arterial hypertension.
Topics: Aminopyridines; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Humans; Hypertension, Pulmonary; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Vascular Resistance; Walk Test; Withholding Treatment | 2018 |
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
Topics: Aminopyridines; Analgesics; Animals; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia; Indoles; KCNQ Potassium Channels; Lung; Male; Membrane Potentials; Muscle, Smooth; Potassium Channel Blockers; Pulmonary Artery; Pulmonary Circulation; Pyridines; Rats; Rats, Wistar; Vascular Resistance | 2015 |
Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rats; Rats, Wistar | 2009 |
Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
Topics: Aminopyridines; Animals; Disease Models, Animal; Female; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels, Voltage-Gated; Pulmonary Artery; Serotonin Plasma Membrane Transport Proteins | 2009 |
Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
Topics: Adult; Aminopyridines; Amrinone; Cardiac Catheterization; Cardiac Output; Female; Humans; Hydralazine; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1983 |